BE896727A - Dihydropyridylimidates cycliques. - Google Patents

Dihydropyridylimidates cycliques.

Info

Publication number
BE896727A
BE896727A BE0/210755A BE210755A BE896727A BE 896727 A BE896727 A BE 896727A BE 0/210755 A BE0/210755 A BE 0/210755A BE 210755 A BE210755 A BE 210755A BE 896727 A BE896727 A BE 896727A
Authority
BE
Belgium
Prior art keywords
dihydropyridylimidates
cyclic
cyclic dihydropyridylimidates
Prior art date
Application number
BE0/210755A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US06/360,758 priority Critical patent/US4414213A/en
Priority to SE8302332A priority patent/SE457725B/sv
Priority to CA000426767A priority patent/CA1238046A/fr
Priority to GB08311433A priority patent/GB2139212B/en
Priority to JP58074179A priority patent/JPS59204189A/ja
Priority to AU14260/83A priority patent/AU566346B2/en
Priority to LU84797A priority patent/LU84797A1/fr
Priority to NL8301672A priority patent/NL8301672A/nl
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to BE0/210755A priority patent/BE896727A/fr
Priority to FR8307978A priority patent/FR2545826B1/fr
Priority to DE19833317691 priority patent/DE3317691A1/de
Priority to AT0181483A priority patent/AT377259B/de
Priority to CH2786/83A priority patent/CH654837A5/de
Publication of BE896727A publication Critical patent/BE896727A/fr
Priority to SE8404458A priority patent/SE460194B/sv
Priority to SE8404459A priority patent/SE457953B/sv
Priority to GB08617590A priority patent/GB2185978B/en
Priority to AU81943/87A priority patent/AU606630B2/en
Priority to AU81942/87A priority patent/AU608260B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
BE0/210755A 1982-03-22 1983-05-11 Dihydropyridylimidates cycliques. BE896727A (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
US06/360,758 US4414213A (en) 1982-03-22 1982-03-22 Dihydropyridyl cyclic imidate esters and their pharmaceutical use
SE8302332A SE457725B (sv) 1982-03-22 1983-04-25 Cykliska dihydropyridyl-imidatestrar, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner
CA000426767A CA1238046A (fr) 1982-03-22 1983-04-26 Esters imidates dihydropyridyliques cycliques et leur utilisation en pharmacie
GB08311433A GB2139212B (en) 1982-03-22 1983-04-27 Dihydropyridyl cyclic imidate esters
JP58074179A JPS59204189A (ja) 1982-03-22 1983-04-28 ジヒドロピリジル環状イミデ−トエステル
AU14260/83A AU566346B2 (en) 1982-03-22 1983-05-05 Dihydro-pyridyl cyclic imidate esters
LU84797A LU84797A1 (fr) 1982-03-22 1983-05-10 Dihydropyridylimidates cycliques
NL8301672A NL8301672A (nl) 1982-03-22 1983-05-10 Dihydropyridyl cyclische imidaatesters; farmaceutische preparaten voor het behandelen van cardiovasculaire ziekten; werkwijze voor het uitoefenen van een vaatverwijdende werking in zoogdieren; antihypertensieve methode; anti-ischemie-methode; werkwijze voor het bereiden van dihydropyridyl cyclische imidaatesters; werkwijze voor het bereiden van cyclische imidaatesterenaminen; cyclische imidaatesterenaminen; werkwijze voor het bereiden van acetylcinnamaatverbindingen; acetylcinnamaatverbindingen.
BE0/210755A BE896727A (fr) 1982-03-22 1983-05-11 Dihydropyridylimidates cycliques.
FR8307978A FR2545826B1 (fr) 1982-03-22 1983-05-13 Dihydropyridylimidates cycliques, et leur application pharmacologique
DE19833317691 DE3317691A1 (de) 1982-03-22 1983-05-16 Cyclische dihydropyridylimidatester, verfahren zu ihrer herstellung und pharmazeutische mittel
AT0181483A AT377259B (de) 1982-03-22 1983-05-17 Verfahren zur herstellung von dihydropyridylimidatestern
CH2786/83A CH654837A5 (de) 1982-03-22 1983-05-20 Cyclische dihydropyridylimidatester, verfahren zu ihrer herstellung und pharmazeutische mittel.
SE8404458A SE460194B (sv) 1982-03-22 1984-09-05 Nya mellanprodukter foer framstaellning av cykliska dihydropyridyl-imidatestrar och foerfarande foer framstaellning daerav
SE8404459A SE457953B (sv) 1982-03-22 1984-09-05 Estrar av ketokarboxylsyror samt foerfarande foer framstaellning daerav
GB08617590A GB2185978B (en) 1983-05-11 1986-07-18 Amino-oxazolylalkenes
AU81943/87A AU606630B2 (en) 1982-03-22 1987-11-30 Acetylcinnamate compounds
AU81942/87A AU608260B2 (en) 1982-03-22 1987-11-30 Cyclic imidate ester enamine compounds

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US06/360,758 US4414213A (en) 1982-03-22 1982-03-22 Dihydropyridyl cyclic imidate esters and their pharmaceutical use
LU84797A LU84797A1 (fr) 1982-03-22 1983-05-10 Dihydropyridylimidates cycliques
BE0/210755A BE896727A (fr) 1982-03-22 1983-05-11 Dihydropyridylimidates cycliques.
AU81942/87A AU608260B2 (en) 1982-03-22 1987-11-30 Cyclic imidate ester enamine compounds
AU81943/87A AU606630B2 (en) 1982-03-22 1987-11-30 Acetylcinnamate compounds

Publications (1)

Publication Number Publication Date
BE896727A true BE896727A (fr) 1983-11-14

Family

ID=40347973

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/210755A BE896727A (fr) 1982-03-22 1983-05-11 Dihydropyridylimidates cycliques.

Country Status (13)

Country Link
US (1) US4414213A (fr)
JP (1) JPS59204189A (fr)
AT (1) AT377259B (fr)
AU (3) AU566346B2 (fr)
BE (1) BE896727A (fr)
CA (1) CA1238046A (fr)
CH (1) CH654837A5 (fr)
DE (1) DE3317691A1 (fr)
FR (1) FR2545826B1 (fr)
GB (1) GB2139212B (fr)
LU (1) LU84797A1 (fr)
NL (1) NL8301672A (fr)
SE (3) SE457725B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB2185978B (en) * 1983-05-11 1987-12-09 Bristol Myers Co Amino-oxazolylalkenes
JPS6191185A (ja) 1984-10-11 1986-05-09 Sumitomo Seiyaku Kk 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
DE3508533A1 (de) * 1985-03-09 1986-09-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von benzylidenverbindungen
US5149814A (en) * 1987-09-30 1992-09-22 Pfizer Inc Alkyl 2-benzylidene-4-(2-alkylimidazopyrid-1-yl) benzoylacetate esters as intermediate compounds
US5070205A (en) * 1987-09-30 1991-12-03 Pfizer Inc. Alkyl 2-benzylidene-4-(benzimidazol-1-yl) benzoylacetate esters as intermediates
MY104933A (en) * 1987-09-30 1994-07-30 Pfizer Ltd Platelet activating factor antagonists
DE4118707A1 (de) * 1991-06-07 1992-12-10 Bayer Ag Pharmazeutische verwendung von 3-formyl-1,4-dihydropyridinen, neue verbindungen und verfahren zu ihrer herstellung
WO1993009774A1 (fr) * 1991-11-18 1993-05-27 G.D. Searle & Co. Derives de 2-(4-substitue)phenylmethylene et procedes d'utilisation
DE60237244D1 (de) * 2001-07-16 2010-09-16 Merck Patent Gmbh Photostabile organische Sonnenschutzmittel mit antioxidativen Eigenschaften
US20070204624A1 (en) * 2006-03-01 2007-09-06 Smith Kenneth O Fuel injector for a turbine engine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511847A (en) * 1967-02-07 1970-05-12 Smithkline Corp 2,6-di-lower alkyl - 1,4-dihydro - 4-(2-trifluoromethylphenyl) - 3,5 - pyridinedicarboxylic acid esters
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2228377A1 (de) * 1972-06-10 1974-01-03 Bayer Ag Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3985758A (en) * 1973-02-20 1976-10-12 Yamanouchi Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
CH655658B (fr) * 1980-09-18 1986-05-15
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
SE457953B (sv) 1989-02-13
GB2139212B (en) 1987-12-09
SE460194B (sv) 1989-09-18
CA1238046A (fr) 1988-06-14
JPH0545595B2 (fr) 1993-07-09
NL8301672A (nl) 1984-12-03
SE8302332L (sv) 1984-10-26
SE8404458L (sv) 1984-10-26
SE8302332D0 (sv) 1983-04-25
AT377259B (de) 1985-02-25
SE8404459D0 (sv) 1984-09-05
JPS59204189A (ja) 1984-11-19
DE3317691A1 (de) 1984-11-22
AU566346B2 (en) 1987-10-15
ATA181483A (de) 1984-07-15
SE8404459L (sv) 1984-10-26
GB2139212A (en) 1984-11-07
FR2545826A1 (fr) 1984-11-16
LU84797A1 (fr) 1984-03-07
AU8194387A (en) 1988-04-14
AU8194287A (en) 1988-04-14
CH654837A5 (de) 1986-03-14
SE8404458D0 (sv) 1984-09-05
SE457725B (sv) 1989-01-23
GB8311433D0 (en) 1983-06-02
AU608260B2 (en) 1991-03-28
FR2545826B1 (fr) 1985-08-23
AU606630B2 (en) 1991-02-14
AU1426083A (en) 1984-11-08
US4414213A (en) 1983-11-08

Similar Documents

Publication Publication Date Title
FI78601B (fi) Engaongsbloeja.
FI78611B (fi) Uppbevaringspaose.
FI73534B (fi) Bandkassett.
FI73505B (fi) Faestelement.
FI77050B (fi) Gelatinkomposition foer sprutgjutning.
FI823990L (fi) Faestningsklaemmare.
FI78606B (fi) Saekerhetssaete.
DE3381054D1 (de) Immunoessay.
BE896727A (fr) Dihydropyridylimidates cycliques.
FI73520B (fi) Maolanordning.
FI840130A (fi) Tvaerbundna urea-formaldehyd-poly- mermatris-kompositioner som innehaoller cykliska mellanstrukturer.
FI824206L (fi) Saogmaskin.
ES272075Y (es) Corretilla.
FI824194L (fi) Foertillverkat betongarmeringselement.
FI824023L (fi) Tapet.
FI824052L (fi) Filtreringspress.
FI73929B (fi) Foerflyttbar lasttransportoer.
FI824188L (fi) Faestsystem foer jordbruksmaskinsbillar.
OA07437A (fr) Dihydropyridylimidates cycliques.
ES263632Y (es) Baldosa-loseta mejorada.
ES269305Y (es) Pulverizador-goteador mejorado.
ATE20348T1 (de) Verbesserte melaminylthioarsenite.
ES265112Y (es) Junquillo.
ES267181Y (es) Alcoholimetro.
ES268319Y (es) Cortaunas bicurvo.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL-MYERS CY

Effective date: 19930531